{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T16:14:10Z","timestamp":1697991250459},"reference-count":27,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T00:00:00Z","timestamp":1151539200000},"content-version":"vor","delay-in-days":8549,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1983,2]]},"abstract":"<jats:p>Murine hybridoma antibodies to a human B\u2010cell lymphoma were developed. After screening against normal T cells, monocytes, and grunulocytes 11 antibodies that reacted with cells from other B\u2010cell lymphomas remained, of which 10 showed individually distinct staining patterns, as tested by indirect fluorescence. When tested against lymphomas or cell lines, none of these antibodies revealed staining patterns suggesting reactivity with conventional B\u2010cell surface markers, such as immunoglobulin, complement factor 3 receptors, or HLA\u2010DR antigens. Only one of the antibodies (GB1) reacted with human serum, as determined by a blocking assay. The antibodies were found to belong to different immunoglobulin isotypes. Two antibodies (GB13 and GB14) reacted with &gt;5% of normal peripheral blood monnnuclcar cells. These reactions were mainly due to reactivity with B cells. The antibodies reacted only in a few cases with acute leukaemias, B\u2010ccll lines, and follicular lymphomas. On the other hand, distinct patterns of reactivity in different histological groups of diffuse lymphomas were obtained, suggesting that the antibodies may be useful in delineating phenotypic subsets among human B\u2010cell lymphomas.<\/jats:p>","DOI":"10.1111\/j.1365-3083.1983.tb00779.x","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T16:29:14Z","timestamp":1151684954000},"page":"161-169","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Delineation of Subsets in Human B\u2010Cell Lymphomas by a Set of Monoclonal Antibodies Raised against B Lymphoma Cells"],"prefix":"10.1111","volume":"17","author":[{"given":"S.","family":"FUNDERUD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"LINDMO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"RUUD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F.","family":"MARTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"LANGHOLM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. F\u00d8LUNG","family":"ELGJO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"VAAGE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"LIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"GODAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.121.6.2322","article-title":"A new B cell differentiation antigen (BDA) on normal and leukaemic human B lymphocytes that is distinct from known DR (la\u2010like) antigens","volume":"121","author":"Balch C.M.","year":"1978","journal-title":"J. Immunol."},{"key":"e_1_2_1_3_2","first-page":"477","article-title":"Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybrldoma secreting antibody against a marker specific for human B lymphocytes","volume":"39","author":"Brooks D.A.","year":"1980","journal-title":"Clin. exp. Immunol."},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.126.4.1373","article-title":"Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes","volume":"126","author":"Brooks D.A.","year":"1981","journal-title":"J. Immunol."},{"key":"e_1_2_1_5_2","first-page":"569","article-title":"Characterization of the receptor for IgM present on human B lymphocytes","volume":"36","author":"Burns G.F.","year":"1979","journal-title":"Immunology"},{"issue":"97","key":"e_1_2_1_6_2","article-title":"Separation of leucocytes from blood and bone marrow","volume":"21","author":"B\u00f8yum A.","year":"1968","journal-title":"Scand. J. clin. Lab. Invest."},{"issue":"5","key":"e_1_2_1_7_2","article-title":"Isolation of lymphocytes, granulocytes and macrophages","volume":"5","author":"Boyum A.","year":"1976","journal-title":"Scand, J. Immunol."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.145.2.357"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60426-1"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910210505"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1982.tb00648.x"},{"key":"e_1_2_1_12_2","first-page":"481","article-title":"Immmological subsets in human B\u2010cell lymphomas","volume":"14","author":"Godal T.","year":"1981","journal-title":"Scand. J. Immunol."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/newbio246116a0"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.123.4.1548","article-title":"A new mouse myeloma cell line that has lost immunoglobutin expression but permits the construction of antibody\u2010secreting hybrid cell lines","volume":"123","author":"Kearney J.F.","year":"1979","journal-title":"J. Immunol."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910180405"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0"},{"key":"e_1_2_1_17_2","first-page":"91","article-title":"Cell\u2010associated immunoglobutin in human non\u2010Hodgkin lymphomas. A comparative study of surface immuno\u2010gtobulin by immunohistochemistry","volume":"89","author":"Landaas T.\u00f8.","year":"1981","journal-title":"Acta path. microblol. scand. Sect. A."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-81092-3"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.126.5.1941","article-title":"Characterization of a human B cell\u2010specific antigen (B2) distinct from B1","volume":"126","author":"Nadler L.M.","year":"1981","journal-title":"J. Immunol."},{"key":"e_1_2_1_20_2","first-page":"477","article-title":"Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient","volume":"7","author":"Nilsson K.","year":"1970","journal-title":"Clin. exp. Immunol."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(76)90120-4"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90072-0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.1.96"},{"key":"e_1_2_1_24_2","first-page":"286","article-title":"Fc receptors for IgG, IgM and IgE on human Ieukaenmic lymphocytes","volume":"35","author":"Spiegelberg J.I.","year":"1979","journal-title":"Clin. exp. Immunol."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.125.4.1678"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.6.3848"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910170504"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.149.6.1424"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.1983.tb00779.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.1983.tb00779.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:34:20Z","timestamp":1697762060000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.1983.tb00779.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1983,2]]}},"alternative-id":["10.1111\/j.1365-3083.1983.tb00779.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.1983.tb00779.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,2]]},"assertion":[{"value":"2006-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}